Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 111

Results For "medicines"

1419 News Found

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre
News | April 10, 2022

AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre

With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country


Knowledge Centre for Pharmaceutical Continuous Manufacturing
Biotech | April 08, 2022

Knowledge Centre for Pharmaceutical Continuous Manufacturing

Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms


CDMOs shifting focus to meet future demand
News | April 07, 2022

CDMOs shifting focus to meet future demand

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines


Hataali wins US patent for the use of blockchain in advanced medicinal therapy
Digitisation | April 06, 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy

The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award


ENTOD Pharma bullish on Macushield sales
News | April 06, 2022

ENTOD Pharma bullish on Macushield sales

Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision


Alvotech and STADA pave way to launching Hukyndra
Biotech | April 06, 2022

Alvotech and STADA pave way to launching Hukyndra

All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved


Lupin signs deal with Alvion for cardiometabolic drugs in Southeast Asia
Biotech | April 05, 2022

Lupin signs deal with Alvion for cardiometabolic drugs in Southeast Asia

Lupin is committed to providing new affordable treatment options to healthcare providers and patients


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


Novartis announces new organizational structure
Biotech | April 04, 2022

Novartis announces new organizational structure

New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity